Psyence Biomedical (PBM) Return on Assets (2024 - 2026)

Psyence Biomedical's (PBM) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 33.75% quarter-over-quarter from 0.0% in Q3 2025.

Psyence Biomedical (PBM) Return on Assets (2024 - 2026) Analysis & Trends

Psyence Biomedical's Return on Assets history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 0.0% change from a year earlier, with the FY2026 full-year figure at 0.01%, changed 0.0% from the prior year.
  • Return on Assets climbed to 0.0% in Q1 2026 per PBM's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.02% in Q3 2024.
  • The 3-year median for Return on Assets is 0.0% (2026), against an average of 0.01%.
  • Across the five-year window, Return on Assets climbed 2 bps in 2025 and changed 0 bps in 2026, its largest moves.
  • Year by year, Return on Assets stood at 0.02% in 2024, then soared by 93 bps to 0.0% in 2025, then jumped by 34 bps to 0.0% in 2026.
  • Per Business Quant, the three latest PBM Return on Assets figures stand at 0.0% (Q1 2026), 0.0% (Q3 2025), and 0.0% (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.69%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -0.01%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -0.80%
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 0.00%
10 Psyence Biomedical 1.56 Mn 1.56 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Sep 30, 2025 0.00%
Mar 31, 2025 0.00%
Sep 30, 2024 -0.02%